메뉴 건너뛰기




Volumn 50, Issue 6, 2013, Pages 827-835

Dipeptidyl peptidase-4 inhibitors in cardioprotection: A promising therapeutic approach

Author keywords

Cardiovascular disease; DPP 4; GLP 1

Indexed keywords

ALOGLIPTIN; ANAGLIPTIN; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 1 [9-36]; GLUCAGON LIKE PEPTIDE 2; GRANULOCYTE COLONY STIMULATING FACTOR; LINAGLIPTIN; NEUROPEPTIDE Y; PEPTIDE YY; PFK 275 055; SAXAGLIPTIN; SITAGLIPTIN; STROMAL CELL DERIVED FACTOR 1ALPHA; SUBSTANCE P; UNCLASSIFIED DRUG; VILDAGLIPTIN;

EID: 84890570105     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0496-4     Document Type: Review
Times cited : (14)

References (69)
  • 1
    • 46849101007 scopus 로고    scopus 로고
    • Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: A pooled analysis of 5 intravascular ultrasound trials
    • 18634979 10.1016/j.jacc.2008.03.051 1:CAS:528:DC%2BD1cXoslWmtLw%3D
    • Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I et al (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255-262
    • (2008) J Am Coll Cardiol , vol.52 , pp. 255-262
    • Nicholls, S.J.1    Tuzcu, E.M.2    Kalidindi, S.3    Wolski, K.4    Moon, K.W.5    Sipahi, I.6
  • 2
    • 78751634660 scopus 로고    scopus 로고
    • Device-based antihypertensive therapy: Therapeutic modulation of the autonomic nervous system
    • 21242507 10.1161/CIRCULATIONAHA.110.971580
    • Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123:209-215
    • (2011) Circulation , vol.123 , pp. 209-215
    • Krum, H.1    Sobotka, P.2    Mahfoud, F.3    Böhm, M.4    Esler, M.5    Schlaich, M.6
  • 3
    • 79958100222 scopus 로고    scopus 로고
    • Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle
    • 21576655 10.1161/CIRCULATIONAHA.110.004341 1:CAS:528:DC%2BC3MXntVersb8%3D
    • Mital S, Chung WK, Colan SD, Sleeper LA, Manlhiot C, Arrington CB et al (2011) Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation 123:2353-2362
    • (2011) Circulation , vol.123 , pp. 2353-2362
    • Mital, S.1    Chung, W.K.2    Colan, S.D.3    Sleeper, L.A.4    Manlhiot, C.5    Arrington, C.B.6
  • 4
    • 77953809302 scopus 로고    scopus 로고
    • The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: Principal results of the diabetic atherosclerosis prevention by cilostazol (DAPC) study: A randomized trial
    • 20516379 10.1161/CIRCULATIONAHA.109.892414 1:CAS:528:DC%2BC3cXns1yltb4%3D
    • Katakami N, Kim YS, Kawamori R, Yamasaki Y et al (2010) The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (DAPC) study: a randomized trial. Circulation 121:2584-2591
    • (2010) Circulation , vol.121 , pp. 2584-2591
    • Katakami, N.1    Kim, Y.S.2    Kawamori, R.3    Yamasaki, Y.4
  • 5
    • 84874404357 scopus 로고    scopus 로고
    • Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II
    • 23439103 10.1016/S0140-6736(13)60108-7
    • Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381:639-650
    • (2013) Lancet , vol.381 , pp. 639-650
    • Farooq, V.1    Van Klaveren, D.2    Steyerberg, E.W.3    Meliga, E.4    Vergouwe, Y.5    Chieffo, A.6
  • 6
    • 84871328289 scopus 로고    scopus 로고
    • Compelling evidence for coronary-bypass surgery in patients with diabetes
    • 23121324 10.1056/NEJMe1212278 1:CAS:528:DC%2BC38XhvVyrsrrL
    • Hlatky MA (2012) Compelling evidence for coronary-bypass surgery in patients with diabetes. N Engl J Med 367:2437-2438
    • (2012) N Engl J Med , vol.367 , pp. 2437-2438
    • Hlatky, M.A.1
  • 7
    • 77956369911 scopus 로고    scopus 로고
    • Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha
    • 20566666 10.2337/db10-0638 1:CAS:528:DC%2BC3cXht12ku77P
    • Zheng Z, Chen H, Wang H, Ke B, Zheng B, Li Q et al (2010) Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha. Diabetes 59:2315-2325
    • (2010) Diabetes , vol.59 , pp. 2315-2325
    • Zheng, Z.1    Chen, H.2    Wang, H.3    Ke, B.4    Zheng, B.5    Li, Q.6
  • 8
    • 45549089895 scopus 로고    scopus 로고
    • Rhythm control versus rate control for atrial fibrillation and heart failure
    • 18565859 10.1056/NEJMoa0708789 1:CAS:528:DC%2BD1cXns1Wrtr0%3D
    • Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667-2677
    • (2008) N Engl J Med , vol.358 , pp. 2667-2677
    • Roy, D.1    Talajic, M.2    Nattel, S.3    Wyse, D.G.4    Dorian, P.5    Lee, K.L.6
  • 9
    • 84872847888 scopus 로고    scopus 로고
    • Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart
    • 23168336 10.1161/CIRCRESAHA.111.300003 1:CAS:528:DC%2BC3sXhtFygu7s%3D
    • Beca S, Ahmad F, Shen W, Liu J, Makary S, Polidovitch N et al (2013) Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart. Circ Res 112:289-297
    • (2013) Circ Res , vol.112 , pp. 289-297
    • Beca, S.1    Ahmad, F.2    Shen, W.3    Liu, J.4    Makary, S.5    Polidovitch, N.6
  • 10
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Action to Control Cardiovascular Risk in Diabetes Study Group 18539917 10.1056/NEJMoa0802743 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D
    • Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
    • Gerstein, H.C.1    Miller, M.E.2    Byington, R.P.3    Goff, Jr.D.C.4    Bigger, J.T.5
  • 11
    • 84861131970 scopus 로고    scopus 로고
    • Incretin-based therapies and cardiovascular risk
    • 22439700 10.1185/03007995.2012.678940 1:CAS:528:DC%2BC38Xnt1anu7w%3D
    • Mannucci E, Dicembrini I (2012) Incretin-based therapies and cardiovascular risk. Curr Med Res Opin 28:715-721
    • (2012) Curr Med Res Opin , vol.28 , pp. 715-721
    • Mannucci, E.1    Dicembrini, I.2
  • 12
    • 80052072913 scopus 로고    scopus 로고
    • Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: Evidence for improving cardiac metabolic efficiency
    • 21887274 10.1371/journal.pone.0023570 1:CAS:528:DC%2BC3MXht1Sqt7rI
    • Bao W, Aravindhan K, Alsaid H, Chendrimada T, Szapacs M, Citerone DR et al (2011) Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency. PLoS ONE 6:e23570
    • (2011) PLoS ONE , vol.6 , pp. 23570
    • Bao, W.1    Aravindhan, K.2    Alsaid, H.3    Chendrimada, T.4    Szapacs, M.5    Citerone, D.R.6
  • 13
    • 43249089631 scopus 로고    scopus 로고
    • Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
    • 18427132 10.1161/CIRCULATIONAHA.107.739938 1:CAS:528:DC%2BD1cXltFyltrY%3D
    • Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117:2340-2350
    • (2008) Circulation , vol.117 , pp. 2340-2350
    • Ban, K.1    Noyan-Ashraf, M.H.2    Hoefer, J.3    Bolz, S.S.4    Drucker, D.J.5    Husain, M.6
  • 14
    • 84855428526 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells
    • 22120969 10.1038/aps.2011.149 1:CAS:528:DC%2BC38XhtFKqtw%3D%3D
    • Ding L, Zhang J (2012) Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells. Acta Pharmacol Sin 33:75-81
    • (2012) Acta Pharmacol Sin , vol.33 , pp. 75-81
    • Ding, L.1    Zhang, J.2
  • 15
    • 84861018492 scopus 로고    scopus 로고
    • GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
    • 22496442 10.1177/1479164112441526
    • Mundil D, Cameron-Vendrig A, Husain M (2012) GLP-1 receptor agonists: a clinical perspective on cardiovascular effects. Diab Vasc Dis Res 9:95-108
    • (2012) Diab Vasc Dis Res , vol.9 , pp. 95-108
    • Mundil, D.1    Cameron-Vendrig, A.2    Husain, M.3
  • 16
    • 84875409178 scopus 로고    scopus 로고
    • Coadministration of glucagon-like Peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia
    • 23248172 10.2337/db12-0797 1:CAS:528:DC%2BC3sXpvFCkur4%3D
    • Tan TM, Field BC, McCullough KA, Troke RC, Chambers ES, Salem V et al (2013) Coadministration of glucagon-like Peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes 62:1131-1138
    • (2013) Diabetes , vol.62 , pp. 1131-1138
    • Tan, T.M.1    Field, B.C.2    McCullough, K.A.3    Troke, R.C.4    Chambers, E.S.5    Salem, V.6
  • 17
    • 31844433106 scopus 로고    scopus 로고
    • The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes
    • 16385384 10.1007/s00125-005-0098-y 1:CAS:528:DC%2BD28XhtFWnuro%3D
    • Zander M, Madsbad S, Deacon CF, Holst JJ (2006) The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes. Diabetologia 49:369-374
    • (2006) Diabetologia , vol.49 , pp. 369-374
    • Zander, M.1    Madsbad, S.2    Deacon, C.F.3    Holst, J.J.4
  • 18
    • 77951168113 scopus 로고    scopus 로고
    • Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice
    • 20097729 10.2337/db09-0955
    • Sauvé M, Ban K, Momen MA, Zhou YQ, Henkelman RM, Husain M et al (2010) Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes 59:1063-1073
    • (2010) Diabetes , vol.59 , pp. 1063-1073
    • Sauvé, M.1    Ban, K.2    Momen, M.A.3    Zhou, Y.Q.4    Henkelman, R.M.5    Husain, M.6
  • 19
    • 77951812608 scopus 로고    scopus 로고
    • The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
    • 20207816 10.1152/ajpheart.00867.2009 1:CAS:528:DC%2BC3cXmt1Kmurk%3D
    • Ye Y, Keyes KT, Zhang C, Perez-Polo JR, Lin Y, Birnbaum Y (2010) The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am J Physiol Heart Circ Physiol 298:H1454-H1465
    • (2010) Am J Physiol Heart Circ Physiol , vol.298
    • Ye, Y.1    Keyes, K.T.2    Zhang, C.3    Perez-Polo, J.R.4    Lin, Y.5    Birnbaum, Y.6
  • 20
    • 79959966874 scopus 로고    scopus 로고
    • Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats
    • 21088878 10.1007/s10557-010-6271-7 1:CAS:528:DC%2BC3MXktF2itLk%3D
    • Huisamen B, Genis A, Marais E, Lochner A (2011) Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. Cardiovasc Drugs Ther 25:13-20
    • (2011) Cardiovasc Drugs Ther , vol.25 , pp. 13-20
    • Huisamen, B.1    Genis, A.2    Marais, E.3    Lochner, A.4
  • 21
    • 37349104226 scopus 로고    scopus 로고
    • Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema
    • 18025295 10.1161/HYPERTENSIONAHA.107.096552 1:CAS:528:DC%2BD2sXhsVagurfF
    • Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J et al (2008) Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 51:141-147
    • (2008) Hypertension , vol.51 , pp. 141-147
    • Byrd, J.B.1    Touzin, K.2    Sile, S.3    Gainer, J.V.4    Yu, C.5    Nadeau, J.6
  • 22
    • 84878895774 scopus 로고    scopus 로고
    • Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells
    • 20455069 10.1007/s00592-010-0195-3
    • Pala L, Pezzatini A, Dicembrini I, Ciani S, Gelmini S, Vannelli BG et al (2012) Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. Acta Diabetol 49:S59-S63
    • (2012) Acta Diabetol , vol.49
    • Pala, L.1    Pezzatini, A.2    Dicembrini, I.3    Ciani, S.4    Gelmini, S.5    Vannelli, B.G.6
  • 23
    • 79953320085 scopus 로고    scopus 로고
    • Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries
    • 21194356 10.1515/bc.2011.002 1:CAS:528:DC%2BC3MXkvFCrtr8%3D
    • Matheeussen V, Baerts L, De Meyer G, De Keulenaer G, Van der Veken P, Augustyns K et al (2011) Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol Chem 392:189-198
    • (2011) Biol Chem , vol.392 , pp. 189-198
    • Matheeussen, V.1    Baerts, L.2    De Meyer, G.3    De Keulenaer, G.4    Van Der Veken, P.5    Augustyns, K.6
  • 24
    • 77950267745 scopus 로고    scopus 로고
    • Glucagon-like peptide (GLP)-1(9-36) amide-mediated cytoprotection is blocked by exendin (9-39) yet does not require the known GLP-1 receptor
    • 20172966 10.1210/en.2009-1197 1:CAS:528:DC%2BC3cXks1CmtrY%3D
    • Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH et al (2010) Glucagon-like peptide (GLP)-1(9-36) amide-mediated cytoprotection is blocked by exendin (9-39) yet does not require the known GLP-1 receptor. Endocrinology 151:1520-1531
    • (2010) Endocrinology , vol.151 , pp. 1520-1531
    • Ban, K.1    Kim, K.H.2    Cho, C.K.3    Sauvé, M.4    Diamandis, E.P.5    Backx, P.H.6
  • 25
    • 4344605042 scopus 로고    scopus 로고
    • Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
    • 15313949 10.1161/01.CIR.0000139339.85840.DD 1:CAS:528: DC%2BD2cXms1OgtLw%3D
    • Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L et al (2004) Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 110:955-961
    • (2004) Circulation , vol.110 , pp. 955-961
    • Nikolaidis, L.A.1    Elahi, D.2    Hentosz, T.3    Doverspike, A.4    Huerbin, R.5    Zourelias, L.6
  • 27
    • 36349012043 scopus 로고    scopus 로고
    • Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes
    • 17890220 10.1074/jbc.M704896200 1:CAS:528:DC%2BD2sXhtlSltr3E
    • Kim SJ, Nian C, McIntosh CH (2007) Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J Biol Chem 282:34139-34147
    • (2007) J Biol Chem , vol.282 , pp. 34139-34147
    • Kim, S.J.1    Nian, C.2    McIntosh, C.H.3
  • 28
    • 80054110585 scopus 로고    scopus 로고
    • Native incretins prevent the development of atherosclerotic lesions in apolipoprotein e knockout mice
    • 21786155 10.1007/s00125-011-2241-2 1:CAS:528:DC%2BC3MXhtFGgurjK
    • Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J et al (2011) Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia 54:2649-2659
    • (2011) Diabetologia , vol.54 , pp. 2649-2659
    • Nagashima, M.1    Watanabe, T.2    Terasaki, M.3    Tomoyasu, M.4    Nohtomi, K.5    Kim-Kaneyama, J.6
  • 29
    • 71349084062 scopus 로고    scopus 로고
    • The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
    • 19900491 10.1016/j.regpep.2009.11.001 1:CAS:528:DC%2BD1MXhsFGgtrrN
    • Bremholm L, Hornum M, Andersen UB, Holst JJ (2010) The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters. Regul Pept 159:67-71
    • (2010) Regul Pept , vol.159 , pp. 67-71
    • Bremholm, L.1    Hornum, M.2    Andersen, U.B.3    Holst, J.J.4
  • 30
    • 29744462729 scopus 로고    scopus 로고
    • Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form
    • 16254193 10.1373/clinchem.2005.057638 1:CAS:528:DC%2BD28Xitlygtw%3D%3D
    • Brandt I, Lambeir AM, Ketelslegers JM, Vanderheyden M, Scharpé S, De Meester I (2006) Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52:82-87
    • (2006) Clin Chem , vol.52 , pp. 82-87
    • Brandt, I.1    Lambeir, A.M.2    Ketelslegers, J.M.3    Vanderheyden, M.4    Scharpé, S.5    De Meester, I.6
  • 31
    • 80052808787 scopus 로고    scopus 로고
    • Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms
    • 21558448 10.1161/CIRCHEARTFAILURE.110.958033 1:CAS:528:DC%2BC3MXhtFyqtrnL
    • Moilanen AM, Rysä J, Mustonen E, Serpi R, Aro J, Tokola H et al (2011) Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail 4:483-495
    • (2011) Circ Heart Fail , vol.4 , pp. 483-495
    • Moilanen, A.M.1    Rysä, J.2    Mustonen, E.3    Serpi, R.4    Aro, J.5    Tokola, H.6
  • 32
    • 0027494070 scopus 로고
    • Proteolytic processing of neuropeptide y and peptide YY by dipeptidyl peptidase IV
    • 7907802 10.1016/0167-0115(93)90435-B 1:CAS:528:DyaK2cXks1GqtQ%3D%3D
    • Mentlein R, Dahms P, Grandt D, Krüger R (1993) Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49:133-144
    • (1993) Regul Pept , vol.49 , pp. 133-144
    • Mentlein, R.1    Dahms, P.2    Grandt, D.3    Krüger, R.4
  • 33
    • 34447116241 scopus 로고    scopus 로고
    • Neuropeptide y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
    • 17603492 10.1038/nm1611 1:CAS:528:DC%2BD2sXnsFWmt70%3D
    • Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD et al (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13:803-811
    • (2007) Nat Med , vol.13 , pp. 803-811
    • Kuo, L.E.1    Kitlinska, J.B.2    Tilan, J.U.3    Li, L.4    Baker, S.B.5    Johnson, M.D.6
  • 34
    • 0036815816 scopus 로고    scopus 로고
    • Effects of ACE inhibitor and beta-adrenergic blocker on plasma NPY and NPY receptors in aortic vascular smooth muscle cells from SHR and WKY rats
    • 12450741 10.1016/S0143-4179(02)00087-2 1:CAS:528:DC%2BD38Xps12jsr0%3D
    • Zeng C, Wang X, Liu G, Yang C (2002) Effects of ACE inhibitor and beta-adrenergic blocker on plasma NPY and NPY receptors in aortic vascular smooth muscle cells from SHR and WKY rats. Neuropeptides 36:353-361
    • (2002) Neuropeptides , vol.36 , pp. 353-361
    • Zeng, C.1    Wang, X.2    Liu, G.3    Yang, C.4
  • 35
    • 62949195390 scopus 로고    scopus 로고
    • Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction
    • 19341621 10.1016/j.stem.2009.02.013 1:CAS:528:DC%2BD1MXltVeqsro%3D
    • Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R et al (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4:313-323
    • (2009) Cell Stem Cell , vol.4 , pp. 313-323
    • Zaruba, M.M.1    Theiss, H.D.2    Vallaster, M.3    Mehl, U.4    Brunner, S.5    David, R.6
  • 36
    • 0032507962 scopus 로고    scopus 로고
    • Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
    • 9634238 10.1038/31269 1:CAS:528:DyaK1cXjvV2qsr4%3D
    • Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599
    • (1998) Nature , vol.393 , pp. 595-599
    • Zou, Y.R.1    Kottmann, A.H.2    Kuroda, M.3    Taniuchi, I.4    Littman, D.R.5
  • 37
    • 77958195997 scopus 로고    scopus 로고
    • The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha
    • 20357375 10.2337/dc10-0187 1:CAS:528:DC%2BC3cXpslKgsrY%3D
    • Fadini GP, Boscaro E, Albiero M, Menegazzo L, Frison V, de Kreutzenberg S et al (2010) The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care 33:1607-1609
    • (2010) Diabetes Care , vol.33 , pp. 1607-1609
    • Fadini, G.P.1    Boscaro, E.2    Albiero, M.3    Menegazzo, L.4    Frison, V.5    De Kreutzenberg, S.6
  • 38
    • 35549004526 scopus 로고    scopus 로고
    • Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats
    • 17726157 10.1124/jpet.107.126847 1:CAS:528:DC%2BD2sXht1ynsLbF
    • Jackson EK, Zhang M, Liu W, Mi Z (2007) Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 323:431-437
    • (2007) J Pharmacol Exp Ther , vol.323 , pp. 431-437
    • Jackson, E.K.1    Zhang, M.2    Liu, W.3    Mi, Z.4
  • 39
    • 0026326713 scopus 로고
    • Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme
    • 1726123 10.1016/0196-9781(91)90220-J 1:CAS:528:DyaK38Xlt1Whtg%3D%3D
    • Wang LH, Ahmad S, Benter IF, Chow A, Mizutani S, Ward PE (1991) Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 12:1357-1364
    • (1991) Peptides , vol.12 , pp. 1357-1364
    • Wang, L.H.1    Ahmad, S.2    Benter, I.F.3    Chow, A.4    Mizutani, S.5    Ward, P.E.6
  • 40
    • 80052661942 scopus 로고    scopus 로고
    • Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
    • 21752744 10.1016/j.scr.2011.05.003 1:CAS:528:DC%2BC3MXhtFCrurnO
    • Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, Brunner S et al (2011) Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. Stem Cell Res 7:244-255
    • (2011) Stem Cell Res , vol.7 , pp. 244-255
    • Theiss, H.D.1    Vallaster, M.2    Rischpler, C.3    Krieg, L.4    Zaruba, M.M.5    Brunner, S.6
  • 41
    • 78650023641 scopus 로고    scopus 로고
    • Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)-rationale, design and first interim analysis
    • 20051299 10.1016/j.ijcard.2009.09.555
    • Theiss HD, Brenner C, Engelmann MG, Zaruba MM, Huber B, Henschel V et al (2010) Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)-rationale, design and first interim analysis. Int J Cardiol 145:282-284
    • (2010) Int J Cardiol , vol.145 , pp. 282-284
    • Theiss, H.D.1    Brenner, C.2    Engelmann, M.G.3    Zaruba, M.M.4    Huber, B.5    Henschel, V.6
  • 42
    • 84879416505 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond
    • Fadini GP, Avogaro A (2013) Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond. Atherosclerosis 18
    • (2013) Atherosclerosis , vol.18
    • Fadini, G.P.1    Avogaro, A.2
  • 43
    • 84875371654 scopus 로고    scopus 로고
    • Restoring stem cell mobilization to promote vascular repair in diabetes
    • 23369723 10.1016/j.vph.2013.01.003 1:CAS:528:DC%2BC3sXisVOqtrg%3D
    • Albiero M, Avogaro A, Fadini GP (2013) Restoring stem cell mobilization to promote vascular repair in diabetes. Vascul Pharmacol 58:253-258
    • (2013) Vascul Pharmacol , vol.58 , pp. 253-258
    • Albiero, M.1    Avogaro, A.2    Fadini, G.P.3
  • 44
    • 84869876137 scopus 로고    scopus 로고
    • Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy
    • 23184393 10.1007/s00395-012-0313-1
    • Fadini GP, Albiero M, Seeger F, Poncina N, Menegazzo L, Angelini A et al (2013) Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol 108:313
    • (2013) Basic Res Cardiol , vol.108 , pp. 313
    • Fadini, G.P.1    Albiero, M.2    Seeger, F.3    Poncina, N.4    Menegazzo, L.5    Angelini, A.6
  • 46
    • 81855222104 scopus 로고    scopus 로고
    • Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis
    • 22007077 10.1161/CIRCULATIONAHA.111.041418 1:CAS:528:DC%2BC3MXhsFantrjJ
    • Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z et al (2011) Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124:2338-2349
    • (2011) Circulation , vol.124 , pp. 2338-2349
    • Shah, Z.1    Kampfrath, T.2    Deiuliis, J.A.3    Zhong, J.4    Pineda, C.5    Ying, Z.6
  • 47
    • 84874597960 scopus 로고    scopus 로고
    • Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice
    • 23337530 10.1210/en.2012-1855 1:CAS:528:DC%2BC3sXjsF2rt7w%3D
    • Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S et al (2013) Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology 154:1260-1270
    • (2013) Endocrinology , vol.154 , pp. 1260-1270
    • Ervinna, N.1    Mita, T.2    Yasunari, E.3    Azuma, K.4    Tanaka, R.5    Fujimura, S.6
  • 48
    • 84855831988 scopus 로고    scopus 로고
    • Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states
    • 22123671 10.1097/MOL.0b013e32834d68f0 1:CAS:528:DC%2BC38XmtFKrsg%3D%3D
    • Farr S, Adeli K (2012) Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states. Curr Opin Lipidol 23:56-61
    • (2012) Curr Opin Lipidol , vol.23 , pp. 56-61
    • Farr, S.1    Adeli, K.2
  • 49
    • 79951933599 scopus 로고    scopus 로고
    • Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
    • 21226820 10.1111/j.1463-1326.2011.01362.x 1:CAS:528:DC%2BC3MXktlylu7s%3D
    • Tremblay AJ, Lamarche B, Deacon CF, Weisnagel SJ, Couture P (2011) Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. Diabetes Obes Metab 13:366-373
    • (2011) Diabetes Obes Metab , vol.13 , pp. 366-373
    • Tremblay, A.J.1    Lamarche, B.2    Deacon, C.F.3    Weisnagel, S.J.4    Couture, P.5
  • 50
    • 33746690405 scopus 로고    scopus 로고
    • Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes
    • 16816950 10.1007/s00125-006-0340-2 1:CAS:528:DC%2BD28XnslSitbo%3D
    • Matikainen N, Mänttäri S, Schweizer A, Ulvestad A, Mills D, Dunning BE et al (2006) Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. Diabetologia 49:2049-2057
    • (2006) Diabetologia , vol.49 , pp. 2049-2057
    • Matikainen, N.1    Mänttäri, S.2    Schweizer, A.3    Ulvestad, A.4    Mills, D.5    Dunning, B.E.6
  • 51
    • 84859463659 scopus 로고    scopus 로고
    • Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: A randomised double-blind placebo-controlled study
    • 22237690 10.1007/s00125-011-2447-3 1:CAS:528:DC%2BC38Xjs1Sjsrw%3D
    • Eliasson B, Möller-Goede D, Eeg-Olofsson K, Wilson C, Cederholm J, Fleck P et al (2012) Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia 55:915-925
    • (2012) Diabetologia , vol.55 , pp. 915-925
    • Eliasson, B.1    Möller-Goede, D.2    Eeg-Olofsson, K.3    Wilson, C.4    Cederholm, J.5    Fleck, P.6
  • 52
    • 80051785333 scopus 로고    scopus 로고
    • DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice
    • 21558879 10.1097/FJC.0b013e31821e5626 1:CAS:528:DC%2BC3MXhtVWjtLbK
    • Ta NN, Schuyler CA, Li Y, Lopes-Virella MF, Huang Y (2011) DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 58:157-166
    • (2011) J Cardiovasc Pharmacol , vol.58 , pp. 157-166
    • Ta, N.N.1    Schuyler, C.A.2    Li, Y.3    Lopes-Virella, M.F.4    Huang, Y.5
  • 53
    • 79251604529 scopus 로고    scopus 로고
    • Sitagliptin reduces albuminuria in patients with type 2 diabetes
    • 21206136 10.1507/endocrj.K10E-382 1:CAS:528:DC%2BC3MXmtF2hsbw%3D
    • Hattori S (2011) Sitagliptin reduces albuminuria in patients with type 2 diabetes. Endocr J 58:69-73
    • (2011) Endocr J , vol.58 , pp. 69-73
    • Hattori, S.1
  • 55
    • 84874111992 scopus 로고    scopus 로고
    • A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
    • 23062489 10.1016/j.metabol.2012.09.004 1:CAS:528:DC%2BC38XhsV2qtL%2FN
    • Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R et al (2013) A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism 62:347-351
    • (2013) Metabolism , vol.62 , pp. 347-351
    • Satoh-Asahara, N.1    Sasaki, Y.2    Wada, H.3    Tochiya, M.4    Iguchi, A.5    Nakagawachi, R.6
  • 56
    • 84870053428 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats
    • 22932707 10.1097/FJC.0b013e31826be204 1:CAS:528:DC%2BC38Xhs1GisbbN
    • Mason RP, Jacob RF, Kubant R, Ciszewski A, Corbalan JJ, Malinski T (2012) Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats. J Cardiovasc Pharmacol 60:467-473
    • (2012) J Cardiovasc Pharmacol , vol.60 , pp. 467-473
    • Mason, R.P.1    Jacob, R.F.2    Kubant, R.3    Ciszewski, A.4    Corbalan, J.J.5    Malinski, T.6
  • 57
    • 84865492970 scopus 로고    scopus 로고
    • Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism
    • 22868389 10.1161/HYPERTENSIONAHA.112.195115 1:CAS:528:DC%2BC38Xht1SiurzM
    • Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX et al (2012) Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism. Hypertension 60:833-841
    • (2012) Hypertension , vol.60 , pp. 833-841
    • Liu, L.1    Liu, J.2    Wong, W.T.3    Tian, X.Y.4    Lau, C.W.5    Wang, Y.X.6
  • 58
    • 77955406467 scopus 로고    scopus 로고
    • Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)
    • 20652060 10.1155/2010/592760
    • Ferreira L, Teixeira-de-Lemos E, Pinto F, Parada B, Mega C, Vala H et al (2010) Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm 2010:592760
    • (2010) Mediators Inflamm , vol.2010 , pp. 592760
    • Ferreira, L.1    Teixeira-De-Lemos, E.2    Pinto, F.3    Parada, B.4    Mega, C.5    Vala, H.6
  • 59
    • 79951677095 scopus 로고    scopus 로고
    • Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats
    • 21150640 10.1097/HJH.0b013e328341939d 1:CAS:528:DC%2BC3MXhvVyktbo%3D
    • Pacheco BP, Crajoinas RO, Couto GK, Davel AP, Lessa LM, Rossoni LV et al (2011) Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats. J Hypertens 29:520-528
    • (2011) J Hypertens , vol.29 , pp. 520-528
    • Pacheco, B.P.1    Crajoinas, R.O.2    Couto, G.K.3    Davel, A.P.4    Lessa, L.M.5    Rossoni, L.V.6
  • 60
    • 41849099939 scopus 로고    scopus 로고
    • Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension
    • 18353996 10.1177/0091270008316885 1:CAS:528:DC%2BD1cXlvVGqsbs%3D
    • Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA et al (2008) Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol 48:592-598
    • (2008) J Clin Pharmacol , vol.48 , pp. 592-598
    • Mistry, G.C.1    Maes, A.L.2    Lasseter, K.C.3    Davies, M.J.4    Gottesdiener, K.M.5    Wagner, J.A.6
  • 61
    • 79955952000 scopus 로고    scopus 로고
    • Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes
    • 21304217 10.1620/tjem.223.133 1:CAS:528:DC%2BC3MXjs12qs7s%3D
    • Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Mori T et al (2011) Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes. Tohoku J Exp Med 223:133-135
    • (2011) Tohoku J Exp Med , vol.223 , pp. 133-135
    • Ogawa, S.1    Ishiki, M.2    Nako, K.3    Okamura, M.4    Senda, M.5    Mori, T.6
  • 62
    • 80052382658 scopus 로고    scopus 로고
    • The metabolic syndrome influences the response to incretin-based therapies
    • 21574000 10.1007/s00592-011-0296-7 1:CAS:528:DC%2BC3MXhtV2qs7rM
    • Fadini GP, de Kreutzenberg SV, Gjini R, Avogaro A (2011) The metabolic syndrome influences the response to incretin-based therapies. Acta Diabetol 48:219-225
    • (2011) Acta Diabetol , vol.48 , pp. 219-225
    • Fadini, G.P.1    De Kreutzenberg, S.V.2    Gjini, R.3    Avogaro, A.4
  • 63
    • 84867136387 scopus 로고    scopus 로고
    • Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
    • 10.1152/ajprenal.00259.2012
    • Rieg T, Gerasimova M, Murray F, Masuda T, Tang T, Rose M et al (2011) Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. Am J Physiol Renal Physiol 303:F963-F971
    • (2011) Am J Physiol Renal Physiol , vol.303
    • Rieg, T.1    Gerasimova, M.2    Murray, F.3    Masuda, T.4    Tang, T.5    Rose, M.6
  • 64
    • 84555209178 scopus 로고    scopus 로고
    • Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure
    • 22045924 10.1093/eurjhf/hfr146 1:CAS:528:DC%2BC3MXhs1CqurbN
    • Gomez N, Touihri K, Matheeussen V, Da Costa AM, Mahmoudabady M, Mathieu M et al (2012) Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure. Eur J Heart Fail 14:14-21
    • (2012) Eur J Heart Fail , vol.14 , pp. 14-21
    • Gomez, N.1    Touihri, K.2    Matheeussen, V.3    Da Costa, A.M.4    Mahmoudabady, M.5    Mathieu, M.6
  • 65
    • 80055110463 scopus 로고    scopus 로고
    • Effects of DPP-4 inhibition on cardiac metabolism and function in mice
    • 21871459 10.1016/j.yjmcc.2011.08.001 1:CAS:528:DC%2BC3MXhsVaqtLbN
    • Lenski M, Kazakov A, Marx N, Böhm M, Laufs U (2011) Effects of DPP-4 inhibition on cardiac metabolism and function in mice. J Mol Cell Cardiol 51:906-918
    • (2011) J Mol Cell Cardiol , vol.51 , pp. 906-918
    • Lenski, M.1    Kazakov, A.2    Marx, N.3    Böhm, M.4    Laufs, U.5
  • 66
    • 80051795160 scopus 로고    scopus 로고
    • Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
    • 21664294 10.1016/j.vph.2011.05.001 1:CAS:528:DC%2BC3MXhtVKmurvI
    • Fadini GP, Avogaro A (2011) Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascul Pharmacol 55:10-16
    • (2011) Vascul Pharmacol , vol.55 , pp. 10-16
    • Fadini, G.P.1    Avogaro, A.2
  • 67
    • 80053358548 scopus 로고    scopus 로고
    • Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
    • 21955567 10.1186/1475-2840-10-85 1:CAS:528:DC%2BC3MXhs1Wjtb7I
    • Yin M, Silljé HH, Meissner M, van Gilst WH, de Boer RA (2011) Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure. Cardiovasc Diabetol 10:85
    • (2011) Cardiovasc Diabetol , vol.10 , pp. 85
    • Yin, M.1    Silljé, H.H.2    Meissner, M.3    Van Gilst, W.H.4    De Boer, R.A.5
  • 68
    • 33751557143 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
    • Sitagliptin Study 019 Group 17157112 10.1016/j.clinthera.2006.10.007 1:CAS:528:DC%2BD28XhtlartrzE
    • Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P, Sitagliptin Study 019 Group (2006) Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 28:1556-1568
    • (2006) Clin Ther , vol.28 , pp. 1556-1568
    • Rosenstock, J.1    Brazg, R.2    Andryuk, P.J.3    Lu, K.4    Stein, P.5
  • 69
    • 77958030736 scopus 로고    scopus 로고
    • Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    • 20824678 10.1002/dmrr.1114 1:CAS:528:DC%2BC3cXhsVCrtbvK
    • Scheen AJ, Charpentier G, Ostgren CJ, Hellqvist A, Gause-Nilsson I (2010) Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 26:540-549
    • (2010) Diabetes Metab Res Rev , vol.26 , pp. 540-549
    • Scheen, A.J.1    Charpentier, G.2    Ostgren, C.J.3    Hellqvist, A.4    Gause-Nilsson, I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.